牛的免疫反应:三同位症和三耐受性:主要发现和差距
Gnohion Fabrice Somé1,2,3, Modou Séré1,4, Bienvenu Martin Somda1,5
1Centre International de Recherche-Développement Sur l'Elevage en Zone Subhumide (CIRDES), Bobo-Dioulasso, Burkina Faso.
Parasite immunology
|November 7, 2024
概括
由Trypanosoma寄生虫引起的非洲动物试索马症,在撒哈拉以南非洲摧毁了牲畜. 了解牛的免疫力是制定可持续控制策略的关键,以对抗这种使人衰弱的疾病.
科学领域:
- 兽医免疫学 兽医免疫学
- 寄生虫学的寄生虫学
- 畜牧业疾病研究研究
背景情况:
- 由Trypanosoma寄生虫引起的非洲动物试症是撒哈拉以南非洲的主要牲畜疾病.
- 牛是最重要的宿主物种,但它们对试体的免疫反应尚未完全理解.
- 基于小鼠模型的现有知识对牛免疫系统与这些寄生虫的相互作用提供了有限的洞察力.
研究的目的:
- 审查目前关于牛对Trypanosoma感染的免疫反应的知识.
- 为了探索牛的免疫力如何减轻非洲动物试索索菌的影响.
- 为了确定了解开发可持续的疾病控制战略的差距.
主要方法:
- 关于牛松症现有研究的文献综述.
- 对宿主-病原体相互作用的分析,专注于免疫参与.
- 综合关于牛的先天性,炎症性和适应性免疫反应的信息.
主要成果:
- 该审查详细介绍了感染过程,并讨论了牛的试耐受性.
- 介绍了调节宿主先天性,炎症性和适应性反应的进展.
- 确定了免疫激活和抑制的关键免疫学参与者.
结论:
- 讨论了牛群免疫耐受性和敏感性的机制.
- 在试索症期间,牛免疫学方面的关键知识缺口需要进一步调查.
- 这一综述为旨在控制疾病的未来研究提供了基础.
相关概念视频
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


